Petco Health & Wellness Company, Inc. - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Petco Health & Wellness Company, Inc. (Petco), covering the thirteen-week period ended May 3, 2025. Petco operates as a single reportable segment, functioning as a pet specialty retailer with an omnichannel ecosystem comprising over 1,500 pet care centers in the U.S., Mexico, and Puerto Rico, alongside digital channels.
Key Financial Metrics
| Metric | Q1 2025 (13 weeks) | Q1 2024 (13 weeks) |
|---|---|---|
| Total Net Sales | $1,493.4 million | $1,529.1 million |
| Gross Profit | $569.9 million | $578.7 million |
| Gross Margin | 38.2% | 37.8% |
| Operating Income | $16.4 million | ($16.8) million |
| Net Loss | ($11.7) million | ($46.5) million |
| Adjusted EBITDA | $89.4 million | $75.6 million |
| Free Cash Flow | ($43.9) million | ($41.1) million |
| Cash & Equivalents | $133.3 million | $165.8 million (Feb 1, 2025) |
| Total Debt (Principal) | $1,595.3 million | $1,595.3 million |
| ABL Availability | $514.6 million | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 2.3% year-over-year, driven by lower transaction volume, a reduced pet care center count (1,393 vs. 1,423), and a strategic focus on profitability over volume. Consumables sales fell 2.1%, while Supplies and companion animals dropped 4.3%. Conversely, Services and other revenue grew 0.8%.
- Profitability Improvement: The company returned to operating profitability, recording $16.4 million in operating income compared to a $16.8 million loss in the prior year. This was achieved through a 140 basis point improvement in gross margin and a reduction in SG&A expenses as a percentage of sales (37.1% vs. 38.9%).
- Net Loss Reduction: Net loss attributable to common stockholders narrowed significantly to $11.7 million from $46.5 million, aided by lower interest expense ($33.5 million vs. $36.8 million) and reduced equity-based compensation costs.
- Cash Flow: Net cash used in operating activities increased to $15.5 million from $8.4 million, primarily due to lower sales and higher payouts of prior-year accrued incentive bonuses, partially offset by reduced inventory purchases.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted momentum in the services segment, driven by strategic investments in customer acquisition and retention, as well as optimization of the veterinary hospital footprint. The company is prioritizing margin expansion and profitability over top-line growth.
Liquidity: Total liquidity stands at $647.9 million, comprising $133.3 million in cash and $514.6 million in available borrowing capacity under the Asset-Based Lending (ABL) Revolving Credit Facility. Management believes current resources are sufficient for operations and capital investments for the next 12 months.
Risks and Contingencies:
- Macroeconomic Factors: Ongoing exposure to inflation, interest rate pressures, tariffs, and global geopolitical developments.
- Competition: Increased competition from multi-channel, mass, and grocery retailers.
- Operational Risks: Reliance on key vendors, supply chain constraints, and the ability to manage costs effectively.
- Legal: The company is subject to ordinary course litigation; management does not currently expect a material adverse effect, though outcomes remain uncertain.
Investor Verification Checklist
- Store Count Impact: Verify the long-term impact of the reduced pet care center count (down 30 stores) on future comparable sales and revenue.
- Services Growth Sustainability: Assess whether the growth in the services segment can offset declines in product sales to drive overall revenue stability.
- Debt Servicing: Monitor the weighted average interest rate (7.9%) on the $1.6 billion term loan and the impact of potential rate hikes on future interest expense.
- Free Cash Flow: Review the continued negative free cash flow trend ($43.9 million outflow) and the company's ability to fund capital expenditures without eroding liquidity.
- Inventory Management: Confirm that inventory levels ($645.5 million) remain optimized to support margin improvements without risking stockouts or obsolescence.